The objective of this article is to provide an update on the diagnosis, assessment, and management of anxiety disorders in adults. This article covers the following disorders: panic disorder, panic attacks, specific phobia, social anxiety disorder and generalized anxiety disorder. Selective mutism and separation anxiety disorder, being childhood anxiety disorders, will not be covered. Obsessive compulsive disorder and post-traumatic stress disorder, which are not categorized as anxiety disorders in DSM-5, will not be covered.
INTRODUCTION
The objective of this article is to provide an update on the diagnosis, assessment and management of anxiety disorders in adults.
In the progression from DSM-IV to the present DSM-5 (2013), the anxiety disorders of the former DSM-IV have been organized into 3 separate categories in DSM-5. 1 These are:
1-Anxiety disorders (separation anxiety disorder, selective mutism, specific phobia, social phobia, panic disorder, agoraphobia, and generalized anxiety disorder).
2-Obsessive-compulsive disorders (obsessive-compulsive disorder, body dysmorphic disorder, hoarding disorder, trichotillomania, and excoriation disorder).
3-Trauma and stress-related disorders (reactive attachment disorder, disinhibited social engagement disorder, PTSD, acute stress disorder, and adjustment disorder).
The focus of this article is on anxiety disorders in adults and only the following will be covered: panic disorder and panic attacks; agoraphobia; social anxiety disorder (SAD); and generalized anxiety disorder (GAD).
Three recently published CPGs on anxiety disorders were reviewed namely, the Australian New Zealand guideline (2018) 2 , the Singapore MOH guideline (2015) 3, 4 , and the Canadian guideline (2014) 5 . Useful and new information from these guidelines have been included into this article where relevant.
The DSM-5 diagnostic criteria of anxiety disorders have been included in the appendix of this article as an aide memoire.
The Mental Health Situation in Singapore
The key findings from the Singapore Mental Health Survey (SMHS) 2016 and published in 2019 8 show that: • One in seven people in Singapore has experienced a mood, anxiety or alcohol use disorder in their lifetime. The lifetime prevalence and 12-month prevalence breakdown by type of disorder is shown in Table 1 .
• Among the conditions assessed in this study, Major Depressive Disorder (MDD), alcohol abuse and ObsessiveCompulsive Disorder (OCD) emerged as the top three mental disorders in Singapore.
• MDD was the most common with one in 16 people in Singapore having had the condition at some point in their lifetime, while alcohol abuse and OCD affected one in 24 and one in 28 people, respectively.
• Socio-demographic characteristics such as age, gender, ethnicity, marital status, education, employment and income status were factors associated with the prevalence of mental disorders.
• The proportion of the people with mental disorders who were not seeking help remains high, and a significant treatment gap remains. Comparing the results of the 2016 SMHS study with the 2010 SMHS study, it was observed that:
• There was an increase in lifetime prevalence of mental illness from 12 percent in 2010 to 13.9 percent in 2016.
• The lifetime prevalence of almost all mental disorders showed an increase. However, the increase was statistically significant only for generalized Anxiety Disorder (GAD) and alcohol abuse.
• While there was no significant change in the proportion of people with a mental illness in their lifetime who did not seek help, persons who sought help had done so earlier.
Definition of anxiety
Anxiety may be defined as a mood state characterized by worry, apprehension and physical symptoms. It is used to describe the physical and psychological response to a feared situation. Anxiety is a normal human physiological mechanism designed to help the body respond to a threat. It arises in response to the perception of a threat to our well-being.
Anxiety serves a useful protective function in that it helps us to either tackle the source of the threat or to run away from it -the so-called "fight or flight response". The autonomic changes that occur in anxiety are essential to avoid danger. Moderate anxiety can actually improve performance. However, anxiety symptoms can also get out of hand, impairing one's usual functioning and leading to the development of an anxiety disorder [6] [7] .
Symptoms of anxiety
Anxiety involves both physical and mental responses, manifesting as physical and psychological symptoms 6 . (Table 2 )
Diagnosis of Anxiety Disorder
With such a wide array of symptoms, it may appear difficult to make a diagnosis of an anxiety disorder. Furthermore, these symptoms can also be caused by many other medical conditions.
The family physician, however, has the advantage of being able to see the patient over a period of time. It is important to take note of the symptoms that the patient presents with and consider an anxiety disorder when there is a constellation of different somatic symptoms which cannot be attributed to a physical or medical disorder. A probe into the psychological symptoms, such as, irritability, worrying thoughts and sleep disturbance may then make the diagnosis obvious.
Patient Assessment
When faced with a patient with symptoms of anxiety, how do we differentiate normal anxiety from an anxiety disorder?
The following provide an approach 6 : 1 Is what the patient experiencing Pathological? 2 What is the Pattern of the symptoms described? 3 What are the present stressors and Problems faced by the patient? 4 What can I do Practically for the patient? 5 Is a Psychiatric referral necessary?
Is what the patient experiencing Pathological?
Anxiety becomes a disorder when:
• it is out of proportion to the danger or threat causing it • it continues even when the danger or stimulus is no longer present • it results in significant distress and impairment in social, academic, occupational or other important areas of functioning • it leads to avoidant behaviour
It is important to exclude other conditions, both medical and psychiatric, which have associated anxiety symptoms.
Source: Lee, 2010 6 (Adapted)
Medical Conditions for Exclusion
Medical conditions that can be associated with anxiety are shown in Table 3 . These conditions may aggravate or mimic anxiety symptoms.
What is the pattern of the symptoms described?
The pattern of symptoms often gives a clue to the type of anxiety disorder the patient may have. (Table 4) 3. What are the present stressors and problems faced by the patient? One question that comes to mind when dealing with any psychiatric disorder should be "why now?"
Patients usually present to us when their stressors go beyond their normal ability to cope.
When this happens, we need to understand the changes in the person's environment that have caused the de-compensation. While it is important to make the correct diagnosis so as to be able to prescribe the correct medical treatment, knowing the current stressors allows us to help the patient holistically and provide resources to the patient to help deal with the underlying issues.
What can I do practically for the patient?

4-1 Psychological therapy
Psychological treatment 4 for an anxious patient may be in the form of simple interventions that can be employed easily even in a busy clinic setting.
a. Therapeutic alliance
The establishment of a therapeutic relationship is key. This therapeutic alliance is vital to the process of emotional and psychological healing and sets the foundation for all subsequent interventions. The family physician is well-placed to do this as he/she has obtained the trust of the patient and his/her family through years of collaborative interaction.
1-Panic disorder
• Recurrent unexpected panic attacks, in the absence of triggers • Persistent concern or worry about panic attacks and/or maladaptive behavior change
2-Agoraphobia
• Marked, unreasonable fear or anxiety about two (or more) of the following five situations: 1-Using public transportation; 2-Being in open spaces; 3-Being in enclosed spaces; 4-Standing in line or being in a crowd; 5-Being outside of the home alone • Active avoidance of feared situation due to thoughts that escape might be difficult or help unavailable if panic-like symptoms occur
3-Specific phobia
• Marked, unreasonable fear or anxiety about a specific object or situation, which is actively avoided (e.g., flying, heights, animals, receiving an injection, seeing blood) 
4-Social anxiety disorder
• Marked, excessive or unrealistic fear or anxiety about social situations in which there is possible exposure to scrutiny by others • Active avoidance of feared situation
5-Generalized anxiety disorder (GAD)
• Excessive, difficult to control anxiety and worry (apprehensive expectation) about multiple events or activities (work difficulties or school performance); • Accompanied by symptoms such as restlessness/feeling on edge, easily fatigued, difficulty concentrating, irritability, muscle tension, sleep disturbance. 
6-Substance/Medication-induced Anxiety Disorder
• Panic attacks or anxiety is predominant in the clinical picture • Symptoms developed during or soon after substance intoxication or withdrawal or after exposure to a medication
4-2 Pharmacological therapy
The mainstay of pharmacological treatment for anxiety are the antidepressants. These are effective in both anxiety disorders as well as in depression. In terms of efficacy, all the various antidepressants are about equal or close to equal at about at 60-70% of patients. They vary in their side effect profiles. All antidepressants also take on the average 2-4 weeks to take effect and this should be explained to patient at the outset (Lee, 2010 6 ).
Anti-depressants have 4 advantages -minimal addictive potential; no tolerance effects; have anti-anxiety effects even in the absence of depression; and have minimal withdrawal symptoms (Lee, 2010 6 ).
1-Selective serotonin reuptake inhibitors (SSRIs)
These medications are the first line pharmacological agents used to treat anxiety disorders. They work by preventing the reuptake of serotonin (5HT) by the presynaptic nerve, thus maintaining higher levels of 5-HT in the synapse.
There is a paradoxical increase in anxiety levels during the first two weeks of starting treatment. The anxiolytic effect occurs after two to four weeks. Examples of SSRI's and their therapeutic dosages are listed in Table 5 .
2-Serotonin Noradrenaline Reuptake Inhibitors (SNRIs)
These inhibit the reuptake of serotonin and noradrenaline into the pre-synaptic nerve endings. They have faster onset of action than the SSRI's and little interaction with other drugs. One example is Venlafaxine.
3-Noradrenergic Specific Serotonergic Antidepressant (NaSSA)
The only example in this class is mirtazapine. Its sedative effect is advantageous in patients with insomnia. It also increases appetite and leads to weight gain.
4-Tricyclic Antidepressants (TCAs)
These are also effective for anxiety disorders. They have unpleasant anti-cholinergic side-effects. Fatal arrhythmias occur with overdose.
5-Anti-histamine with anxiolytic properties
One example is hydroxyzine. The therapeutic dosage is 25 -150 mg/day.
6-Benzodiazepines
These are effective in reducing anxiety symptoms of GAD, panic disorder and phobias. Rapid onset of action. For example, in panic disorder, patients frequently think that their symptoms actually herald a heart attack. By educating the patient about the symptoms of a panic attack, the patient will be less fearful when an attack is imminent, thus alleviating the likelihood of triggering the crescendo of anxiety symptoms that follow. Biggest drawback -Chronic use is associated with significant potential problems including tolerance, dependence, withdrawal, relapse, rebound, interactions with other medications and adverse events.
SNRIs
Precautions -The patient should also be advised from the onset that this is not the definitive treatment for the anxiety disorder and it is only meant to provide symptom relief while awaiting the anti-depressant to take effect. Hence, Benzodiazepines should be restricted to short-term use (up to two weeks) when initiating treatment and should not be used as monotherapy. They should be given at the lowest possible dose and gradually tapered off because of its addictive potential. They are contraindicated in those with alcohol or substance abuse. Commonly used examples are Alprazolam, Clonazepam, Diazepam, and Lorazepam.
Pharmacological treatment pointers in anxiety disorders :
1 Start with an SSRI -an adequate dose should be used, adequate duration is eight to twelve months 2 It is okay to prescribe benzodiazepines (BZPs) but watch for abuse/ dependency. It is for use in the short term of 2 to 4 weeks only. 3 Listen actively and give simple problem-solving advice. 4 Encourage relaxation, stress reduction. 5 Review regularly -weekly to bi-weekly for first two to three sessions and monthly to bi-monthly subsequently
Recommendations for pharmacotherapy and psychotherapy in the various anxiety disorders are given in Tables 6 to 9 . Table 6 : Recommendations for pharmacotherapy and psychotherapy for panic disorder Table 7 : Recommendations for pharmacotherapy and psychotherapy in specific phobia 
Not recommended
Either selective serotonin reuptake inhibitors (SSRIs) or venlafaxine should be used 4.5 .
Imipramine and clomipramine are effective 4 .
Benzodiazepines may be added to antidepressants in the short term to produce a more rapid therapeutic response in the treatment of panic disorder. In view of the addictive potential, benzodiazepines should be tapered and withdrawn by 4 weeks 4 .
Buspirone, propranolol, tiagabine, trazodone 5 CBT should be used as first-line treatment for specific phobias.
Benzodiazepines may be used on a shortterm basis for temporary relief in specific phobia, pending resolution of symptoms with other forms of treatment.
Either SSRIs or venlafaxine should be used as first-line pharmacological treatment for GAD. CBT may be used as first-line psychotherapy treatment for GAD Drug treatment for GAD needs to be continued for at least 32 weeks as high relapse rates are reported after discontinuing medications
Imipramine may be considered a secondline treatment for GAD, in view of the possibility of poor tolerability and danger of fatal over dosage
Mirtazapine may be considered a secondline treatment for GAD due to its anxiolytic effects Hydroxyzine may be used as adjunctive treatment together with other anxiolytic agents for treatment of GAD.
Benzodiazepines should not be used for the long term treatment of GAD Propranolol is not recommended for the long term treatment of generalised anxiety disorder.
Either pharmacotherapy or psychotherapy alone may be used as first-line treatment for SAD, depending on patient preferences, values and economic considerations.
Either SSRIs or venlafaxine should be used as first-line pharmacotherapy for SAD Moclobemide may be used for the treatment of SAD if treatment with SSRIs or venlafaxine has not been effective.
Benzodiazepines may be used on a shortterm for temporary anxiety relief pending resolution of phobic symptoms with other forms of treatment.
Beta-blockers (e.g., atenolol, propranolol) are not recommended for the treatment of SAD, as they have been found ineffective. However, they may be used for the treatment of performance anxiety (e.g., playing an instrument, giving a speech). A panic attack is defined as: An abrupt surge of intense fear or intense discomfort that reaches a peak within minutes, and includes ≥4 of the following symptoms:
(1) Palpitations, pounding heart, or accelerated heart rate (2) Sweating 
5) Is a Psychiatric referral necessary?
Most patients with anxiety disorders such as GAD and panic disorder can be managed in a general practice setting.
Patients should be referred when:
• symptoms are severe or complex • symptoms fail to improve with initial treatment and follow-up • co-occurring drug/alcohol abuse • there are psychotic symptoms • there is serious risk of suicide Table A5 . Social anxiety disorder DSM-5 diagnostic criteria Table A6 . generalized anxiety disorder -DSM-5 diagnostic criteria
• Marked fear or anxiety about social situations in which the person may be exposed to scrutiny by others • Fear that actions or showing anxiety symptoms will cause negative evaluation (e.g., embarrassment, humiliation) or offend others • The social situation: almost always provokes fear or anxiety; and is actively avoided or endured with marked fear or anxiety • The fear, anxiety, or avoidance: is out of proportion to the actual threat posed by the social situation; is persistent, typically ≥6 months; and causes significant distress or functional impairment • If another medical condition is present (e.g., stuttering, obesity), the disturbance is unrelated or out of proportion to it • Specify "performance only" if the fear is restricted to speaking or performing in public.
Source: Katzman et al, 2014 5, 9 • Excessive anxiety and worry (apprehensive expectation) about a number of events or activities (e.g., school/work performance) • The individual finds it difficult to control the worry • Excessive anxiety and worry are associated with ≥3 of the following symptoms (with at least some occurring more days than not for ≥6 months): restlessness or feeling keyed-up or on edge; being easily fatigued; difficulty concentrating; irritability; muscle tension; or sleep disturbance • The disturbance causes clinically significant distress or functional impairment.
Source: Katzman et al, 2014 5, 9 
